Publications



Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
JAMA Oncol 2017 May 4. Epub 2017 May 4.
Center for Clinical Cancer Genetics, Department of Medicine, The University of Chicago, Chicago, Illinois8Committee of Genetics, Genomics, and Systems Biology, The University of Chicago, Chicago, Illinois.


DGCR8 is essential for tumor progression following PTEN loss in the prostate.
EMBO Rep 2015 Sep 23;16(9):1219-32. Epub 2015 Jul 23.
The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California - San Francisco, San Francisco, CA, USA Center for Reproductive Sciences, University of California - San Francisco, San Francisco, CA, USA Department of Urology, University of California - San Francisco, San Francisco, CA, USA Department of Anatomic Pathology, University of California - San Francisco, San Francisco, CA, USA.



A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population.
BBA Clin 2014 Dec 8;2:94-102. Epub 2014 Nov 8.
Division of Hematology-Oncology, University of California, San Francisco, CA, USA ; Buck Institute for Research on Aging, Novato, CA, USA.


RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth.
Oncotarget 2014 Jul;5(13):5165-76
Buck Institute for Research on Aging; Novato, CA, USA. Oncology-Hematology Division, Department of Medicine, University of California, San Francisco, CA USA.

FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
Breast Cancer Res Treat 2013 Jun 28;139(2):381-90. Epub 2013 May 28.
Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA.


Biologic markers determine both the risk and the timing of recurrence in breast cancer.
Breast Cancer Res Treat 2011 Sep 20;129(2):607-16. Epub 2011 May 20.
Department of Surgery and Radiology, University of California, San Francisco, CA 94115, USA.




Breast cancer growth prevention by statins.
Cancer Res 2006 Sep;66(17):8707-14
Department of Surgery, University of California San Francisco/Mt. Zion Medical Center, Room C342, 1600 Divisadero, San Francisco, CA 94115, USA.

Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
J Clin Oncol 2006 Sep;24(26):4245-53
Swiss Institute for Experimental Cancer Research, National Center of Competence in Research, Molecular Oncology, Riehen, Switzerland.

Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis.
Biochim Biophys Acta 2002 Aug;1591(1-3):109-118
Department of Anesthesia and Pharmaceutical Chemistry, University of California-San Francisco, SF General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA.


OF